Pharmacokinetics of di-phenyl-di-(2,4-dichlorbenzohydroxamato) tin (IV): A new metal-based candidate with promising antitumor activity in rats

[1]  Yunlan Li,et al.  Mechanisms by which the antitumor compound di‐n‐butyl‐di‐(4‐chlorobenzohydroxamato)tin(IV) induces apoptosis and the mitochondrial‐mediated signaling pathway in human cancer SGC‐7901 cells , 2010, Molecular carcinogenesis.

[2]  Xiao-ru Wang,et al.  Determination of total tin and organotin compounds in shellfish by ICP-MS , 2010 .

[3]  E. Tiekink,et al.  Dibutyltin(IV) complexes containing arylazobenzoate ligands: chemistry, in vitro cytotoxic effects on human tumor cell lines and mode of interaction with some enzymes , 2011, Investigational New Drugs.

[4]  N. Raman,et al.  Metal-based antitumor, cytotoxic and antimicrobial activity: pharmacological evaluation of Knoevenagel condensate β-diketone Schiff base thiosemicarbazone Cu(II) and Zn(II) complexes , 2009 .

[5]  G. Zachariadis,et al.  Speciation of organotin compounds in urine by GC-MIP-AED and GC-MS after ethylation and liquid-liquid extraction. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  Yunlan Li,et al.  Synthesis and antitumor activity of a new mixed-ligand complex di-n-butyl-(4-chlorobenzohydroxamato)tin(IV) chloride. , 2008, Journal of inorganic biochemistry.

[7]  C. Pettinari,et al.  Chemical and Biotechnological Developments in Organotin Cancer Chemotherapy , 2006 .

[8]  Qingshan Li,et al.  Diorganotin(IV) derivatives of substituted benzohydroxamic acids with high antitumor activity. , 2004, Chemistry.

[9]  H. Nishino,et al.  Inhibition of epstein-barr virus early antigen activation promoted by 12-O-tetradecanoylphorbol-13-acetate by the non-steroidal anti-inflammatory drugs. , 2000, Cancer letters.

[10]  S. Hill,et al.  Effect of different spray chambers on the determination of organotin compounds by high-performance liquid chromatography–inductively coupled plasma mass spectrometry , 1996 .

[11]  A. Sanz-Medel,et al.  Determination of butylin ion species by ion-exchange chromatography with inductively coupled plasma mass spectrometric and spectrofluorimetric detection , 1993 .

[12]  M. Gielen,et al.  The acute toxicity and in vivo antitumour activity against L1210 leukemia of triphenyltin 3,5-diisopropylsalicylate, bis (di-n-butyl-(s)-2-pyrrolidone-5-carboxylato)tin oxide and di-n-butyltin bis(3-amino-4-methylbenzoate). , 1993, In vivo.

[13]  A. Silvestri,et al.  The antitumor activity of di-n-butyltin(IV) glycylglycinate, and the correlation with the structure of dialkyltin(IV) glycylglycinates in solution studied by conductivity measurements and by infrared, nuclear magnetic resonance, and Mössbauer spectroscopic methods. , 1985, Journal of inorganic biochemistry.

[14]  G. Atassi,et al.  Investigations into the antitumour activity of organotin compounds. 2. Diorganotin dihalide and dipseudohalide complexes , 1984 .

[15]  H. Parge,et al.  Possible pre-dissociation of diorganotin dihalide complexes: relationship between antitumour activity and structure. , 1984, Cancer letters.

[16]  P. J. Smith,et al.  Investigations into the antitumour activity of organotin compounds. I. Diorganotin dihalide and di-pseudohalide complexes. , 1980, Chemico-biological interactions.